However, Wallace et al. [24] observed that T1D risk correlates with lower CD226 mRNA, which could reduce cell activation on cross-linking, altering the interactions of monocytes with lymphocytes and other immune cells and the CD226 receptors, CD112 and CD155. The gene discussed is CD226; the disease is type 1 diabetes mellitus.